Sentences with phrase «such as cancer therapies»

This technique has been used cautiously in managing a number of clinical indications such as cancer therapy, genetic vaccination, and wound healing.

Not exact matches

Bellicum is among the flurry of biotechs investing heavily into cell therapies such as experimental chimeric antigen receptor T - cell (CAR - T) treatments for cancer (this is the next - gen treatment that involves reprogramming immune cells to become cancer killers and has shown promise in blood cancers, which Bellicum specializes in).

Dr. Bedient is a champion of reproductive freedom, with special interests in fertility preservation for patients undergoing toxic therapies for medical conditions such as cancer, as well as third party reproduction for same - sex couples and LGBT individuals.

During the sessions, U.S. and Cuban scientists explored such topics as the molecular mechanisms cancer cells employ to evade the body's immune system, new tools to image and manipulate that system, and ways to rethink how such therapies can best be deployed to reach patients where they receive health services.

Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.

The type, intensity and duration of immunosuppressive therapy contribute to the risk of developing skin cancer, such as melanoma, after transplantation.

For example, some cancer treatments, such as HER - 2 targeted therapies, can cause weakening of the heart muscle, a condition known as heart failure.

Tissue engineering provides a more practical means for researchers to study cell behavior, such as cancer cell resistance to therapy, and test new drugs or combinations of drugs to treat many diseases.

And in an ironic twist, the work could yield a new way to treat common ailments such as heart disease and cancer with gene therapies.

Therefore, common treatments such as endocrine therapy and molecular targeting of the HER - 2 receptor are not effective for this breast cancer subtype.

New products and developments, such as new drugs for cancer, fresh therapies for rare diseases, progress in medications for HIV / AIDS, and advances in stem cell research had the greatest positive impact.

These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.

Viral therapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients» immune systems, according to findings published today in the journal Molecular Therapy — Oncotherapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients» immune systems, according to findings published today in the journal Molecular Therapy — OncoTherapy — Oncolytics.

This is crucial because therapies, such as cancer drugs, can target histones.

Medical researchers are talking about starting an online archive where they could post unreviewed results from clinical trials, such as one that tested this light therapy for cancer patients.

«LFEX laser» enables us to generate high energy pulses of quantum beams with large current, and one can expect such medical applications as particle beam cancer therapy and non-destructive inspection for bridges and etc. (or defect inspection by gamma - ray beam and neutrons).

CAM therapies, such as yoga and acupuncture, are becoming more common among cancer survivors looking to improve their quality of life, and have been shown to reduce pain, fatigue, and psychological distress.

Gene therapy can be used to neutralise harmful human genes, such as those that cause cancer, or to insert healthy copies of damaged genes into people with a genetic disease.

Of these variants, reported today in the journals Nature and Nature Genetics, 65 are common variants that predispose to breast cancer and a further seven predispose specifically to oestrogen - receptor negative breast cancer - the subset of cases that do not respond to hormonal therapies, such as the drug tamoxifen.

Most people live with the infection without noticeable effect, but it can be life - threatening for people with suppressed immune systems, such as people on cancer therapies or who have HIV / AIDS.

Because those organoids include stroma, a scaffold of connective tissue essential for tumor growth, they may prove better for studying therapies that target the stroma, such as cancer immunotherapy.

Natural botanical dietary supplements such as hops have become increasingly popular among women for postmenopausal symptoms, as they are perceived as a safer alternative to hormone therapy, which has been linked to increased risk of breast cancer.

The process, which located a genetic site for the most common form of prostate cancer, has potential for developing precision therapy for other cancers, such as breast, brain and colorectal, say researchers at The University of Texas MD Anderson Cancer Ccancer, has potential for developing precision therapy for other cancers, such as breast, brain and colorectal, say researchers at The University of Texas MD Anderson Cancer CCancer Center.

«This suggests that PGAM1 inhibitors can sensitize cancers to PARP inhibitors such as Olaparib, thereby expanding the benefits of PARP inhibitors to BRCA1 / 2 - proficient cancers, particularly triple - negative breast cancers that currently lack effective therapies,» says author Min Huang.

Although current antiviral medicines such as nucleos (t) ide analogue therapy could significantly reduce liver cancer risk, Dr. Lee notes these therapies do not completely eliminate the risk.

This also offers the possibility to re-assess the use of vitamin K antagonists such as warfarin in cancer therapy,» concludes Magdalena Paolino.

«This characteristic makes gold nanorods attractive for use in catalysis, security materials and a range of biomedical applications, such as diagnostics, imaging, and cancer therapy,» says Joe Tracy, a materials science and engineering researcher at NC State who is senior author of a recent paper on the improved technique.

The authors conclude that FL118 - based therapy may be beneficial for a subgroup of cancer patients with tumors such as chronic lymphocytic leukemia and melanomas, in which MdmX overexpression confers treatment resistance.

And pinpointing a genetic signature, such as EGFR mutations in lung cancer or HER2 mutations in breast cancer, can guide therapy decisions.

During the past decade, some cancer research has highlighted the potential therapies found in plants, including chemicals found in foods such as turmeric, apple peels and green tea.

The new findings could be used to inform precision - medicine approaches that help minimize a person's risk for common diseases — such as diabetes, cardiovascular disease and cancer — by tailoring diet - based prevention and therapy to the specific needs of an individual.

Gene therapy within the next decade or so is not going to prove very effective in eliminating solid cancers such as lung, breast, prostate, colon and so on.

Standard treatments for ER + breast cancer are endocrine therapies such as tamoxifen and aromatase inhibitors.

This promises to make proton therapy an option for thousands more cancer patients by reducing the risks of healthy tissue being damaged during treatment, particularly in vulnerable parts of the body such as the brain, eye and spinal cord.

There are now more than 100 gene therapy clinical trials aimed toward cancer, genetic diseases (such as ADA deficiency, cystic fibrosis and hemophilia A), infectious diseases (including AIDS) and autoimmune diseases (such as rheumatoid arthritis).

Hot flashes are particularly severe and frequent in breast cancer survivors, but current FDA - approved remedies for these unpleasant episodes, such as hormone replacement therapies are off - limits to breast cancer survivors because they include estrogen.

«Also, we believe that anti-CtBP therapies such as HIPP may be able to complement current therapies to counter drug resistance and decrease metastasis, ultimately increasing our ability to control and cure colon cancer.»

As such, macrophage - based cancer therapies were investigated decades ago.

Because diseases such as cancer tend to evade detection by T - cells» receptors, allowing a tumor to grow unchecked, scientists have long sought «intel» on this process as a means of developing therapies that target malignant cells, but leave healthy cells alone.

Richards describes how the adoption of some of the standard cancer therapies, such as 5 - Fluorouracil and Interferon, was not based on their passing the validity test Moertel and his colleagues had insisted upon in the case of vitamin C.

«Current therapies take advantage of this by using targeted drugs such as Trastuzumab or Lapatinib to specifically inhibit ERBB2, but eventually they become ineffective as the cancer develops resistance to those drugs.»

Current therapies for autoimmune disease, such as prednisone and rituximab, suppress large parts of the immune system, leaving patients vulnerable to potentially fatal opportunistic infections and cancers.

According to Sinclair, all of the mammalian SIRT genes (and their proteins) are possible drug targets for therapies aimed at extending life, as well as staving off age - related illnesses, such as Alzheimer's disease, cancers and metabolic disorders, like diabetes.

This is the first population - based study to compare the follow - up intensity of American men with prostate cancer who have not undergone aggressive treatment with those who opted to undergo various forms of aggressive therapy, such as surgery and radiation.

This complexity contributes to its aggressive nature and resistance to conventional therapies such as chemotherapy and radiation therapy,» says Fisher, Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research program at Massey Cancer Center, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of the VIMM.

Management of low risk prostate cancer with AS appears feasible and safe, yet most men in the U.S. with low risk disease still undergo definitive therapies such as radical prostatectomy, which carry the burden of urinary, bowel, and sexual dysfunction that can be avoided, or at the very least postponed, with management on AAS appears feasible and safe, yet most men in the U.S. with low risk disease still undergo definitive therapies such as radical prostatectomy, which carry the burden of urinary, bowel, and sexual dysfunction that can be avoided, or at the very least postponed, with management on Aas radical prostatectomy, which carry the burden of urinary, bowel, and sexual dysfunction that can be avoided, or at the very least postponed, with management on ASAS.

Technology such as this, scientists said, may have a promising future in the identification and surgical removal of malignant tumors, as well as using near - infrared light therapies that can kill remaining cancer cells, both by mild heating of them and generating reactive oxygen species that can also kill them.

TNBC is deadly because, unlike other types of breast cancers such as estrogen receptor (ER) positive or HER2 amplified breast tumours which have effective targeted therapy, TNBC tumours do not respond to targeted therapy.

The total radiation delivered, 0.5 gray (Gy), was high relative to environmental levels (from sources such as naturally occurring radon in rock), but significantly lower than equivalent human doses experienced in CAT - scans or cancer therapy.

Since the initial discovery of EGFR mutations in lung cancer 10 years ago, EGFR targeted therapies such as erlotinib (Tarceva) and afatinib (Gilotrif) have become a fundamental component of lung cancer therapy.